Methylprednisolone-induced liver injury: Case report and literature review

Journal of Digestive Diseases

Volumn 17, Issue 1, 2016, Pages 55-62

  Davidov, Yana ^a,b   Har Noy, Ofir ^a,b   Pappo, Orit ^c   Achiron, Anat ^d,e   Dolev, Mark ^d   Ben Ari, Ziv ^a,e  

^a Liver Disease Center   (Israel)

^b Institute of Gastroenterology   (Israel)

^c Institute of Pathology   (Israel)

^d SHEBA MEDICAL CENTER   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BILIRUBIN GLUCURONIDE; GAMMA GLUTAMYLTRANSFERASE; METHYLPREDNISOLONE; SMOOTH MUSCLE ANTIBODY; GLUCOCORTICOID;

ABDOMINAL PAIN; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; DISEASE EXACERBATION; DRUG MEGADOSE; EOSINOPHIL COUNT; FEMALE; FEVER; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPERTRANSAMINASEMIA; INTERNATIONAL NORMALIZED RATIO; JAUNDICE; LABORATORY TEST; LIVER BIOPSY; MALAISE; MEDICAL HISTORY; MULTIPLE SCLEROSIS; NAUSEA; OUTPATIENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RELAPSE; TOXIC HEPATITIS; VOMITING; BIOPSY; CHEMICAL AND DRUG INDUCED LIVER INJURY; LIVER; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PATHOLOGY; YOUNG ADULT;

BIOPSY; CHEMICAL AND DRUG INDUCED LIVER INJURY; FEMALE; GLUCOCORTICOIDS; HUMANS; LIVER; METHYLPREDNISOLONE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; YOUNG ADULT;

EID: 84959169617     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/1751-2980.12306     Document Type: Article

References (28)

1. Kleiner DE, Chalasani NP, Lee WM et al.; Drug-Induced Liver Injury Network (DILIN). Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations. Hepatology 2014; 59: 661-70.
2. Topal F, Özaslan E, Akbulut S, Küçükazman M, Yüksel O, Altiparmak E. Methylprednisolone-induced toxic hepatitis. Ann Pharmacother 2006; 40: 1868-71.
3. Reuß R, Retzlaff K, Vogel S, Franke FE, Oschmann P. Autoimmune hepatitis after high-dose intravenous methylprednisolone pulse in RR-MS. Central European J Med 2007; 2: 356-9.
4. Das D, Graham I, Rose J. Recurrent acute hepatitis in patient receiving pulsed methylprednisolone for multiple sclerosis. Indian J Gastroenterol 2006 ; 25: 314-6.
5. Hofstee HM, Nanayakkara PW, Stehouwer CD. Acute hepatitis related to prednisolone. Eur J Intern Med 2005; 16: 209-10.
6. Carrier P, Godet B, Crepin S et al. Acute liver toxicity due to methylprednisolone: consider this diagnosis in the context of autoimmunity. Clin Res Hepatol Gastroenterol 2013; 37: 100-4.
7. Furutama D, Kimura F, Shinoda K, Maeda T, Tanaka T, Ohsawa N. Recurrent high-dose intravenous methylprednisolone succinate pulse therapy-induced hepatopathy in a patient with multiple sclerosis. Med Princ Pract 2011; 20: 291-3.
8. Rivero Fernández M, Riesco JM, Moreira VF et al. Recurrent acute liver toxicity from intravenous methylprednisolone. Rev Esp Enferm Dig 2008; 100: 720-3 (in Spanish).
9. Salvi M, Vannucchi G, Sbrozzi F et al. Onset of autoimmune hepatitis during intravenous steroid therapy for thyroid-associated ophthalmopathy in a patient with Hashimoto's thyroiditis: case report. Thyroid 2004; 14: 631-4.
10. Weissel M, Hauff W. Fatal liver failure after high-dose glucocorticoid pulse therapy in a patient with severe thyroid eye disease. Thyroid 2000; 10: 521.
11. D'Agnolo HM, Drenth JP. High-dose methylprednisolone-induced hepatitis in a patient with multiple sclerosis: a case report and brief review of literature. Neth J Med 2013; 71: 199-202.
12. Melamud B, Lurie Y, Goldin E, Levi I, Esayag Y. Methylprednisolone-induced liver injury: a diagnostic challenge. Isr Med Assoc J 2014; 16: 180-1.
13. Marinò M, Morabito E, Altea MA et al. Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves' ophthalmopathy treated successfully with glucocorticoids themselves. J Endocrinol Invest 2005; 28: 280-4.
14. Loraschi A, Banfi P, Mauri M, Sessa F, Bono G. Cosentino M. Hepatotoxicity after high-dose methylprednisolone for demyelinating disease. Clin Neuropharmacol 2010; 33: 52-4.
15. Marinó M, Morabito E, Brunetto MR, Bartalena L, Pinchera A, Marocci C. Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves' ophthalmopathy. Thyroid 2004; 14: 403-6.
16. Maàmouri N, Ketari S, Ben Hariz F et al. Bolus de méthylprednisolone révélant une hépatite auto-immune chez une patiente atteinte de sclérose en plaques. Journal Africain d'Hépato-Gastroentérologie 2009; 3: 195-7 (in French).
17. Grilli E, Galati V, Petrosillo N, Del Nonno F, Baiocchini A. Incomplete septal cirrhosis after high-dose methylprednisolone therapy and regression of liver injury. Liver Int 2015; 35: 674-6.
18. Alva AS, Bhasin A, Vijayaraghavan S. A rare case of methylprednisolone induced hepatitis. J Clin Exp Hepatol 2013; 3 Suppl 1: S37.
19. Danan G, Benichou C. Causality assessment of adverse reactions to drugs - I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46: 1323-30.
20. Hayashi PH, Fontana RJ. Clinical features, diagnosis, and natural history of drug-induced liver injury. Semin Liver Dis 2014; 34: 134-44.
21. Czaja AJ. Drug-induced autoimmune-like hepatitis. Dig Dis Sci 2011; 56: 958-76.
22. Alonso A, Hernán MA. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 2008; 71: 129-35.
23. Gunawan BK, Kaplowitz N. Mechanisms of drug-induced liver disease. Clin Liver Dis 2007; 11: 459-75.
24. Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov 2005; 4: 489-99.
25. Le Moli R, Baldeschi L, Saeed P, Regensburg N, Mourits MP, Wiersinga WM. Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves' ophthalmopathy. Thyroid 2007; 7: 357-62.
26. Bartalena L, Krassas GE, Wiersinga W et al. European Group on Graves' Orbitopathy. Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy. J Clin Endocrinol Metab 2012 Dec; 97: 4454-63.
27. Gao G, Dai J, Qian Y, Ma F. Meta-analysis of methylprednisolone pulse therapy for Graves' ophthalmopathy. Clin Exp Ophthalmol 2014; 42: 769-77.
28. Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ. Practice Parameters Committee of the American College of Gastroenterology. ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol 2014; 109: 950-66.